WHAT WE OFFER
LapidusData offers two primary services
Epidemiology analyses
LapidusData comprehensively identifies and reviews available data, including published studies and other sources. Our experience in rare disease epidemiology is both deep and broad. When we analyze data sources, our perspective includes:
Population genetics
Can conclusions from one region or market be applied elsewhere? Study design
Was the study methodology effective for this disease, considering both the disease biology and the healthcare system?Statistical significance
Was the study adequately powered for commercial confidence? Are differences among studies due to real-world factors or random chance?This complex lens gives you a meaningful and commercially relevant perspective on your patient population. We analyze every study to push the data as far as we can, while still respecting its limits.
And when we reach those limits, LapidusData can help generate new data from insurance claims, physician surveys, or primary epidemiology studies.
Patient-based forecast models
Gene therapies and other disease-modifying products lead to complex patient dynamics with major impact on market forecasts. Our models carefully apply uptake and survival curves to appropriate patient segments—by disease segment and therapy—to correctly model these dynamics.
Our custom-built models feature:
- A range of scenario controls for a sensitivity analyses
- Highly granular segmentation by disease segment, country, age, and other factors
- A dynamic approach to factors which change over time and across regions, such as diagnosis rates and product uptake
- Commercial factors such as early-access programs and payment-over-time price strategies
- Simple, consistent controls that allow commercial users to produce powerful forecasts